Health Indicators

INDICATOR	YEAR	UNIT	VALUE
ُEstimated population (Lebanese)	2017	1000 citizens	4,421
Total area		Km²	10,452
Population growth rate	2017		1.5
Life expectancy	2012	Years	81.24
Population <15	2017	Percent	24.6
Population > 65	2017	Percent	9.7
Total GDP	2017	Billion US$	53.4
GDP per Capita	2017	US $	12,078
THE per Capita	2015	US $	863
THE % GDP	2015	Percent	7.41
OOP % THE	2015	Percent	32.7
Physicians	2017	Per 10 000 population	31.3
Nurses	2017	Per 10 000 population	34
Midwives	2017	Per 10 000 population	2.4
Dentists	2017	Per 10 000 population	15.2
Beds	2016	Per 10 000 population	27.3

All

ATC	Name	B/G	Ingredients	Form	Price
R05CA12	HEDECTON COUGH	G	Ivy leaf soft extract - 40mg/5ml	Syrup	467,657 L.L
C05AX	HEMOCARE	G	Bismuth subgallate - 100mg, Zinc oxide - 100mg, Lidocaine - 60mg	Suppository	588,731 L.L
A03AX	HEPABYL	G	Sorbitol - 2.5g/5ml, Diisopromine - 0.02g/5ml	Liquid	238,052 L.L
C09DA01	HYZAAR	B	Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg	Tablet	1,740,596 L.L
R06AA52	HISTALIX	G	Diphenhydramine HCl - 14mg/5ml, Ammonium chloride - 135mg/5ml, Menthol - 1.1mg/5ml	Syrup	384,339 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg	Injectable suspension	4,462,901 L.L
J07CA09	HEXASIIL VACCINE (DIPHTERIA, TETANUS, PERTUSSIS, HEPATITIS B, POLIO, HAEMOPHILUS INFLUENZA TYPE B)		Diphteria Toxoid - ?30IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella pertussis (Whole cell) - ?4IU/0.5ml, Hepatitis B, surface antigen - 15mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, H. Influenza type b polysaccharide1 ,2 - 10mcg/0.5ml, 1 conjugated to tetanus protein - 19-33mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - ?1.25mg	Injectable suspension	3,594,779 L.L
R06AB52	HISTAMED-F	G	Dexchlorpheniramine - 2mg/5ml, Dexamethasone - 0.25mg/5ml	Syrup	712,876 L.L
R06AB52	HISTAMED-F	G	Dexchlorpheniramine maleate - 2mg, Dexamethasone - 0.25mg, Fluphenazine HCl - 0.25mg	Tablet, coated	579,772 L.L